openPR Logo
Press release

Gene Logic Ramps up Genomics Momentum

03-19-2009 08:33 PM CET | Science & Education

Press release from: Ocimum Biosolutions

Gene Logic (An Ocimum Biosolutions Company), a leading genomics company, today announced an enhanced range of services through its new interactive website. The website integrates 14 years of research & development in Biomarker Discovery and areas like SNP analysis, Genome Wide Association Studies (GWAS), Microarray Profiling & Genotyping. The website also showcases new priority application areas like Diagnostics, Agriculture, and Food & Nutrition.

Gene Logic, who has been providing Genomics services & solutions since 1995, recently expanded its range of service offerings with the purchase of an Illumina iScan system. The system will be used with the recently released high density Infinium HD assays, Illumina’s most advanced assays, as well as their whole genome expression and methylation technologies. This technology provides clients with another option for GWAS and determination of chromosomal Copy Number Variation in DNA samples. The company is offering a limited time introductory pricing for its services on Illumina platform untill April 30, 2009.

On this launch, Gene Logic encouraged and called for partnerships with organizations and scientists working in areas like Diagnostics, Agro-Tech, Food & Neutraceuticals and other Discovery Areas saying that there is a huge scope of applying genomics in R&D and for improving scientific support mechanisms in a consumers’ perspective.

Anu Acharya, CEO, Gene Logic said, “We have been partnering with many pharma and biotech companies to help them focus on their core competencies and outsource their ‘genomics programs’ to us. We have also recently launched a number of accessible programs for Emerging, Small & Mid-sized biotechs, sector-specific innovators in Diagnostics, Agro-biotech, Neutraceuticals & Food Science.”

She added, “Our new website emerges from a worldwide survey we have been doing for the past few months. It incorporates feedback and suggestions from the genomics community, who have trusted us for over 15 years. This new website signals Gene Logic 2.0 that has geared up to deal with Genomics 2.0 challenges. We are also pleased to launch our new services and products along with our complete genomics outsourcing options. ”

For media and investment related appointments, please contact:
Ms. Nazia Sultana
E-mail: pr@ocimumbio.com

About Gene Logic (An Ocimum Biosolutions Company)

Gene Logic is a leading integrated genomics company providing comprehensive genomic reference databases, life science lab information management solutions, GLP-compliant microarray services and essential research consumables. Over 2/3rd of the top 25 pharma companies, leading research institutes and emerging biotech companies worldwide have chosen us as their preferred outsourcing partner and utilize our expertise for understanding underlying mechanisms of diseases, discovery and prioritization of gene targets and biomarkers.
We are a preferred outsourcing partner for providing integrated biorepository and genomic services for several global pharmaceutical companies. Our global infrastructure, standardized procedures, capacity, expertise and highly skilled staff support drug development programs from pre-clinical target development and toxicogenomic assessment to clinical biomarker identification and patient stratification. In creating the world's largest commercial gene expression databases – BioExpress® and ToxExpress®, we have developed expertise and capabilities that are unparalleled in the genomic services industry. We provide multiple GLP-compliant platforms for gene expression and SNP genotyping data generation. We also provide full biorepository and genomic services support for the Genetic Alliance, which is an umbrella organization representing ~600 genetic advocacy groups. Besides providing the physical infrastructure for storing thousands of biological samples, we provide services to assist sample accrual, IRB approvals, CRO training, sample collection, clinical data capture and management.
For more information, please visit www.genelogic.com

Mayank Kumar
mayank.k@ocimumbio.com
Ocimum Biosolutions Ltd.
6th Floor, Reliance Classic
Road No. 1, Banjara Hills
Hyderabad - 500 034
A.P., India
Telephone +91 40 6662 7200

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gene Logic Ramps up Genomics Momentum here

News-ID: 72472 • Views:

More Releases from Ocimum Biosolutions

Sciantis™ – Ocimum Biosolutions unveils its new software product to handle B …
cimum Biosolutions announces release of its new software product, Sciantis™, a lab process and data management platform for biologics labs. Sciantis™ helps Labs to manage Biologics development process, automate data capturing and support lab Analytics needs. Mr. Subash Lingareddy, CFO, President of Ocimum Biosolutions, said, “Sciantis™ is our new software offering to serve Biologics companies in improving their development process and data management. This software also serves
Ocimum Biosolutions Is Winner of Bioexcellence Award ( Bioinformatics and Systems Biology) at Bio India 2012
Ocimum Biosolutions Is Winner of Bioexcellence Award ( Bioinformatics and System …
Hyderabad, Andhra Pradesh, India, February 07th, 2012: The Jury of Industry experts constituted by ABLE has declared Ocimum Biosolutions as a Bioexcellence Award winner at Bio INDIA BIO 2012 event under Bioinformatics & Systems Biology Category. Ms. Anuradha Acharya, CEO of Ocimum Biosolutions said, “Systems Biology and Bioinformatics will be the backbone of future therapeutics and diagnostics. At Ocimum we are focusing our efforts in these areas to meet the needs of the

More Releases for Gene

Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks. The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies. In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Gene Editing Market : A Market Study On Gene Editing And Cancer Therapy Techniqu …
Global Gene Editing Market Precision Business Insights (PBI) in its report titled “Global Gene Editing Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Gene editing or Genome editing is
Direct-to-consumer Genetic Testing Market: Top Players - Gene By Gene, MyHeritag …
Latest industry research report on: Global and United States Direct-to-consumer Genetic Testing Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report studies the Direct-to-consumer Genetic Testing market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Direct-to-consumer Genetic Testing market by product